CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort:

Lippincott, Williams & Wilkins, Pharmacogenetics and Genomics, 10(24), p. 486-491, 2014

CYP3A422 and CYP3A53 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort:

Journal article published in 2014 by Joseph P. Kitzmiller, Jasmine A. Luzum, Damiano Baldassarre

, Ronald M. Krauss, Marisa W. Medina

This paper is available in a repository.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by